INTRODUCTION
Bacillus anthracis, the agent of anthrax, causes disease primarily in domestic and wild animals. However, it can produce either cutaneous inthrax or an often fatal systemic disease (inhalation or gastrointestinal anthrax) in people exposed to infected animals or their products (4, 6, 13, 22) .
The two major virulence factors of B. anthracis are a poly-D-glutamic acid capsule and an exotoxin, which are encoded by two plasmids \26; B.D.
Green, L. Battisti, and C.B. Thorne, Abstr. Annu. Meet. Am. Soc. Microbiol.
1985, H99, p. 139).
It has been hypothesized that the capsule allows the bacilli to evade early phagocytic defenses (8) , and in vitro studies have demonstrated the anti-phagocytic effect of the capsular material (16) .
Anthrax toxin is composed of three proteins: protective antigen (PA), lethal factor (LF), and edema factor (EF).
In guinea pigs and rabbits, PA combined with EF produces edema in the skin, and PA plus LF injected intravenously causes death in guinea pigs, rats, and mice. None of the proteins by itself possesses toxic activity (3, 9, 22, 35, J6, 38) . Protective antigen is immunogenic and is the major component in the current human anthrax vaccine used in this country (13, 22) .
The pathogenesis of infection by B. arthracis, the role of toxin in the disease, and mechanisms of host defense are poorly understood. Previous studies indicated that animal species vary in their resistance to lethal infection and to killing by the toxin (9, 12, 15, 17, 19, 24, 39 infection, appear to be generally more susceptible to killing by injected toxin than are those that succumb to a small infectious dose. Also, the terminal concentrations of toxin and bacilli in the blood of infected animals were found to vary directly with that species' resistance to toxin. For example, just prior to death, infected guinea pigs had 50 units of toxin per ml of blood and 2 x 108 CFU of B. anthracis per ml. In contrast, blood of moribund rats yielded less than eight toxic units per ml and only 1 x 104 CFU/ml (22, 24) . Thus, resistance to the organisms and susceptibility to the toxin appear to be separate, aspects of pathogenesis (19, 24) .
In order to study pathogenesis and mechanisms of host resistance, an animal model which simulates the range of host responses to anthrax is needed. Abalakin et al. provided evidence for differences in resistance among inbred mice (1). Among six strains tested, five were killed by 400 spores of a fully virulent encapsulated strain of B. anthracis. However, one strain (CC57BR) survived challenge with both the low (4 x 102 CFU) and high (4 x 104 CFU) doses of spores. When challenged with a nonencapsulated, toxin-producing vaccine strain (STI), two mouse strains, A/Sn and DBA/2, died, whereas the other mouse lines tested were resistant. The purpose of our work is to determine the suitability of inbred mice as a model for studying infection by B. anthracis. We have identified and initially characterized eight strains of mice that differ significantly in their susceptibility to infection by B.
anthracis and to lethal intoxication. (25) .
The time-to-death (TTD) for each mouse was also recorded and the geometric and harmonic mean TTD calculated for each dose of B. anthracis (10, 31) . The harmonic mean TTD is determined by the following:
where N is the total number of animals infected per dose and TTD is given in days, with TTD equal to -for survivors. Two different methods were used to perform regression analysis of the dose-dependent ToD for each mouse strain.
In the first, reciprocal harmonic mean TTD values were determined for each dose and strain and then compared by using computer programs ( The Cox method models the survival instead of TTD of infected mice and is based on instantaneous rates of death ("hazard" rates) relative to the given covariates of mouse strain and dose of infecting oryanism. Mouse susceptib ,ity groups were determined in both regression analyses by multiple pairwise comparisons by the Bonferroni method (27) . The susceptibility rankings of the mouse strains derived from both methods were the same.
Virulence testing of toxin ccuponents. Purified LF and PA components of anthrax toxin, and affinity-purified goat anti-PA antibody, were gifts of S.
Leppla (21) . PA and LF were combined in a ratio of 5:1 (w/w), and serial twofold dilutions of the mixture were prepared and injected into A/J and CBA/J mice via the tail vein, as described by Ezzell et al. (9) . 
RESULTS
Eight strains of inbred mice were screened for differences in susceptibility to lethal infection by B. anthracis. Table 1 Despite the similarity in the lethal doses of Vollum 1B for the different mouse strains, analysis of the TTD and probability of survival of animals revealed sianificant strain-related diffeirences. Table 2 and DBA/J mice are not equally susceptible, in that A/J mice succumbed to infection more rapidly than did DBA/2J mice (Fig. 2) .
The pathologic and bacteriologic findings were similar to those previously observed in anthrax-infected animals (13, 15, 17, 19, 22, 23) .
After inoculation with the Vollum 1B strain and just prior to death, the mice became wasted in appearance and very lethargic. In vivo production of toxin by B. aithrecis presumably has a major role in lethality of the mice, as it does for other animals (22, 36) . Encapsulated but nontoxigenic B. anthracis were avirulent for our animals. All of the A/J mice inoculated with doses up to 106 spores (highest dose tested) of Pasteur strain 6602 (capsule +, toxin -) survived the infection (data not shown).
DISCUSSION
Systemic anthrax is a rapidly proyressive and lethal disease caused by toxigenic and encapsulated strains of Bacillus anthracis (4, 6, 13, 22, 26) .
Animal species differ considerably in their natural resistance to this disease. Herbivores are the most frequently infected animals, and empirical data have suggested that cattle and sheep are especially susceptible. Studies with laboratory animals have confirmed the large variation in host resistance (12, 15, 19, 24, 39) . However, the mechanisms of both host resistance and pathogenesis of disease remain obscure.
Development of a lethal infection by B. anthracis requires germination of
the spores at the challenge site, invasion of the bloodstream with systemic multiplication by the bacilli, and toxin production leading to death.
Germination and invasion by the organism appear to be dependent on the presence of specific conditions at the site of inoculation. For instance, Hachisuka found that spores inoculated i.p. into rats were engulfed and destroyed by phayocytic cells (12) . In contrast, spores rapidly germinated and began vegetative replication in the peritoneal cavities of mice, and thus escaped phagocytosis. Rats survived infection whereas mice succumbed to lethal anthrax. Suspension of anthrax spores in substances such as specific phosphatides or a combination of nutrients was shown to decrease the LD 5 0 for rats and hasten the onset of bacteremia (12, 15, 19, 34 ). It appears that differences in the local milieu might be involved in the species variation in resistance to anthrax.
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The inoculation site also influences the pathogenesis and outcome of infection. Although inhalation is presumed to be one of the natural routes of exposure to B. anthracis, animals generally are much more refractory to aerosol than to parenteral challenge (23, 24, 39) . This is probably due in part to the mucociliary barrier to infection presented by the respiratory tract. In contrast to the fate of spores inoculated i.p., spores reaching the alveoli appear to be engulfed by alveolar macrophages and are transported by these cells to local lymph nodes (12, 23, 33, 39 ).
Here they germinate and are released into the lymphatics (33) . The role of the cellular response in the pathogenesis of anthrax at different sites and in different hosts requires further investigation. In sum, these studies suggest that host-and sitespecific responses influence the establishment of infection by B. anthracis and possibly the innate resistance of the animal to lethal disease.
In the present study, we have examined inbred mice as a model for studying host variation in susceptibility to infection by B. anthracis. The course of disease and pathology in lethally infected mice resembled that reported for other animals with anthrax (23). Major, findings in the mice included invasive infection and bacteremia, dark thickened blood, an enlarged dark, and soft spleen, and copious amounts of gelatinous edema.
The susceptibilities of eight mouse strains to infection with B.
anthracis were characterized. In contrast to previous findings by Abalakin and coworkers k1), none of the mouse strains examined was resistant to lethal infection with capsule-and toxin-producing B. anthracis (Vollum 1B).
Nevertheless, one group of mice (Group III - Table 2 for which the macrophage is presumed to play a major role (11, 14, 28) . Both A/J and DBA/2J mice have a genetically-determined deficiency in the C5 protein of complement, and this defect may have a role in susceptibility to some organisms (7) . In vitro data have suggested a role for complement in resistance to B. anthracis. O'Brien et al. (29) showed that normal rabbit serum, but not heat-treated serum, can opsonize the capsule-negative Sterne strain and allow phagocytosis by human PMNs.
Identification of the genetic basis of susceptibility in mice to nonencapsulated B. anthracis woulo be of practical value in vaccine studies.
The efficacy of live attenuated strains in immunization of animals suggests that they might be superior to the widely used PA vaccine in man (13, 18, 37) . The latter induces antibody levels that are low and short-lived (13, 22) . Inbred mice could be used to screen newly developed live vaccine strains for one which protects mice, such as the A/J animals, against challenge with virulent organisms, without itself causing disease.
Evidence for the toxigenic nature of anthrax was provided by Smith and
Keppie more that 30 y ago (35) . In recent studies, Leppla showed that the edema factor of anthrax toxin is an adenylate cyclase in tissue culture cells (21) . However the primary cause of death in anthrax and the molecular action of anthrax toxin in vivo are still unknown (13, 22, 36) .
In past studies, animals injected i.v. with anthrax toxin exhibited a pattern of susceptibility distinct from the pattern following infection.
Generally data showed that species which are relatively resistant to lethal infection, e.g. the rat and dog, are killed by much smaller d-es of toxin than are the species which are susceptible to infection, e.g. guinea pigs (9, 19, 22, 24, 36) . These independent responses to toxin and to infection in an animal suggest that the mechanisms responsible for host defense against spore challenge and lethal toxicity are separate entities. The susceptibility of inbred mice to anthrax toxin was studied using the A/J and CBA/J strains, representing mice that are relatively susceptible or resistant, respectively, to infection. Lethal doses of PA and LF for these mice were similar and agreed well with the value for outbred mice, 12.5 1, PA combined with 2.5 Pg LF (9). However, CBA/J mice were killed more rapidly by toxin than were the spore-susceptible A/J animals. .002) by multiple pairwise comparisons (Bonferroni method) of the regression coefficients for each mouse strain (data not shown).
Comparisons were made at the loglo geometric mean dose (60 spores) of Vollum IB and were made relative to C57BL/6J. Analysis of covariance had confirmed that the slopes of the regression curves for each strain were not statistically different.
b Harmonic mean TTD of mice infected with the geometric mean dose.
Values in parentheses correspond to the 95% conficence interval over the TTD. 
